ALT today
$1.66+$0.05 (+3.01%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourLeaning Bullish
15 minBullish
5 minStrong Bearish
Daily trend turns up above $3.55
Key levels
Resistance$2.00
Resistance$1.83
Support$1.60
Latest news & SEC filings
AnalystB. Riley Securities keeps Buy rating on Altimmune, cuts target to $11
AnalystB. Riley trims its valuation view on Altimmune shares
EarningsAltimmune Discusses Third-Quarter 2026 Results on Conference Call
EarningsAltimmune Posts Q3 2026 Results
All ALT news →About Altimmune
Altimmune develops experimental medicines for severe liver conditions. Its main drug candidate, pemvidutide, is designed to act on two hormone receptors and is being tested in people whose livers accumulate excess fat, as well as those with alcohol use disorder and alcohol-related liver damage. The company is based in the United States and serves patients with these conditions.
Based on the company's 10-K filed Mar 6, 2026.
Nasdaq · Healthcare
Altimmune, Inc. (ALT)
What Is the Price Target for ALT?
SEPT Low Target
$10.00
SEPT Mid Target
$10.50
SEPT High Target
$17.00
Analyst Consensus
$10.50
Is ALT a Buy or Sell Right Now?
Thesis
- •Revenue growing 105.0% YoY with ACCELERATING trend — accelerating momentum.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ALT.
Start Free Trial →Is ALT Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$9.53
27
Moat Score
NONE
4/9
Piotroski Score
-1.4
Altman Z-Score
What Is Smart Money Doing with ALT?
Insider Signal
BUYING
5 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| WEAVER GREGORY L | officer | Buy | 14,475 | - | Oct 1, 2026 |
| WEAVER GREGORY L | officer | Sale | 4,379 | $12K | Oct 1, 2026 |
| Arbet-Engels Christophe | officer | Buy | 37,500 | - | Oct 1, 2026 |
| Arbet-Engels Christophe | officer | Sale | 12,679 | $35K | Oct 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ALT Growth Story
Revenue YoY
105.0%
3yr Revenue CAGR
-79.0%
EPS Growth YoY
25.37%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for ALT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ALT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:16:43 | $1.66 | 1,600 | $$3K | BUY |
| 19:15:12 | $1.66 | 1,000 | $$2K | BUY |
| 19:14:20 | $1.65 | 1,517 | $$3K | SELL |
| 19:14:01 | $1.66 | 1,000 | $$2K | BUY |
| 19:14:01 | $1.66 | 1,600 | $$3K | BUY |
5 dark pool trades shown · $$11K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ALT
PREVIEWSEPT Investing provides real-time options flow tracking for ALT, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $2 | Jan 15 | 63 | $$1400 | 100 | BLOCK |
| CALL | $2 | Jan 15 | 63 | $$2250 | 150 | BLOCK |
| CALL | $2 | Jan 15 | 63 | $$1500 | 100 | BLOCK |
| CALL | $2 | Jan 15 | 63 | $$285 | 19 | SWEEP |
| CALL | $2 | Jan 15 | 63 | $$375 | 25 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About ALT
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for ALT. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
$ALT rating update: B. Riley Securities keeps Buy rating on Altimmune, cuts target to $11.
Join 3,500+ traders discussing ALT in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Altimmune, Inc. (ALT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ALT — frequently asked questions
What is ALT stock price today?
Altimmune, Inc. (ALT) is at $1.66, up 3.01% (+$0.05) at the Nov 13, 2026 close.
Why is ALT stock moving today?
Latest ALT news — Nov 13, 2026: B. Riley Securities keeps Buy rating on Altimmune, cuts target to $11 · Nov 13, 2026: B. Riley trims its valuation view on Altimmune shares
What is the ALT price target?
The average analyst price target for ALT is $10.50, ranging from $10 to $17, based on 4 analysts. Latest: Evercore ISI Group maintains on Sep 23, 2026.
What do analysts rate ALT?
Analyst ratings for ALT: 1 Buy, 4 Hold, 0 Sell — consensus Hold.
Did ALT beat earnings?
ALT last reported on Aug 12, 2026: EPS -$0.12 vs -$0.14 expected — a beat of 11.4%.
Does ALT pay a dividend?
ALT does not currently pay a dividend.
How much debt does ALT have?
Altimmune, Inc. reported $35M of debt and $63M of cash (Jun 30, 2026).
What are ALT support and resistance levels?
Support: $1.60. Resistance: $1.83, $2.00, $2.21.
What are insiders doing with ALT?
Insider activity: BUYING, 5 buys and 0 sells in the last 90 days.
What is the latest news on ALT?
Nov 13, 2026: B. Riley Securities keeps Buy rating on Altimmune, cuts target to $11 · Nov 13, 2026: B. Riley trims its valuation view on Altimmune shares · Nov 12, 2026: Altimmune Discusses Third-Quarter 2026 Results on Conference Call